FERMENTA BIOTECH
|
FERMENTA BIOTECH Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 25.03 | 26.35 | -7.99 | -17.70 | 5.35 |
| CEPS(Rs) | 32.07 | 34.50 | 0.25 | -8.62 | 14.08 |
| DPS(Rs) | 3.75 | 2.50 | 1.25 | 1.25 | 1.25 |
| Book NAV/Share(Rs) | 140.56 | 124.23 | 95.63 | 104.67 | 123.91 |
| Tax Rate(%) | 26.71 | 8.18 | -143.18 | -3.56 | 44.10 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 19.21 | 23.54 | 8.31 | 5.20 | 15.62 |
| EBIT Margin(%) | 20.65 | 20.90 | 2.25 | -8.55 | 11.27 |
| Pre Tax Margin(%) | 18.24 | 17.72 | -2.94 | -14.66 | 6.76 |
| PAT Margin (%) | 13.37 | 16.27 | -7.15 | -15.18 | 3.78 |
| Cash Profit Margin (%) | 17.50 | 21.43 | 0.21 | -7.11 | 10.19 |
| Performance Ratios | |||||
| ROA(%) | 11.13 | 12.85 | -4.01 | -7.63 | 2.04 |
| ROE(%) | 18.36 | 23.93 | -8.30 | -16.11 | 4.27 |
| ROCE(%) | 21.99 | 21.97 | 1.58 | -5.25 | 7.50 |
| Asset Turnover(x) | 0.83 | 0.79 | 0.56 | 0.50 | 0.54 |
| Sales/Fixed Asset(x) | 1.40 | 1.24 | 0.93 | 1.08 | 1.25 |
| Working Capital/Sales(x) | 2.93 | 3.81 | 4.90 | 7.90 | 3.73 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.71 | 0.80 | 1.08 | 0.93 | 0.80 |
| Receivable days | 71.83 | 64.16 | 60.61 | 67.14 | 71.03 |
| Inventory Days | 95.93 | 82.04 | 118.27 | 151.04 | 147.34 |
| Payable days | 147.04 | 164.01 | 155.24 | 131.18 | 150.99 |
| Valuation Parameters | |||||
| PER(x) | 12.75 | 10.38 | - | - | 38.41 |
| PCE(x) | 9.95 | 7.93 | 615.28 | -12.40 | 14.61 |
| Price/Book(x) | 2.27 | 2.20 | 1.58 | 1.02 | 1.66 |
| Yield(%) | 1.18 | 0.91 | 0.83 | 1.17 | 0.61 |
| EV/Net Sales(x) | 1.87 | 1.78 | 1.52 | 1.33 | 2.00 |
| EV/Core EBITDA(x) | 7.96 | 6.83 | 12.84 | 17.44 | 11.29 |
| EV/EBIT(x) | 9.05 | 8.52 | 67.47 | -15.61 | 17.72 |
| EV/CE(x) | 1.91 | 1.77 | 1.21 | 0.88 | 1.06 |
| M Cap / Sales | 1.74 | 1.70 | 1.30 | 0.88 | 1.49 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 11.92 | 39.87 | -4.08 | -12.19 | 5.63 |
| Core EBITDA Growth(%) | 0.83 | 208.12 | 48.17 | -61.99 | -22.50 |
| EBIT Growth(%) | 10.62 | 1,198.94 | 125.23 | -166.63 | -36.40 |
| PAT Growth(%) | -8.05 | 418.23 | 54.81 | -452.79 | -64.59 |
| EPS Growth(%) | -5.01 | 429.95 | 54.88 | -430.53 | -66.06 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.27 | 0.30 | 0.48 | 0.72 | 0.66 |
| Current Ratio(x) | 1.86 | 1.50 | 1.35 | 1.19 | 1.47 |
| Quick Ratio(x) | 1.13 | 1.00 | 0.90 | 0.63 | 0.77 |
| Interest Cover(x) | 8.57 | 6.59 | 0.43 | -1.40 | 2.50 |
| Total Debt/Mcap(x) | 0.12 | 0.14 | 0.30 | 0.69 | 0.39 |
Compare Financial Ratios of peers of FERMENTA BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FERMENTA BIOTECH | ₹1,327.3 Cr | 8.4% | 27.9% | 17% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,408.0 Cr | 1.8% | 5.6% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹206,906.0 Cr | 0.5% | 13.1% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,521.0 Cr | -2.7% | 5.1% | 42.4% | Stock Analytics | |
| CIPLA | ₹119,032.0 Cr | 2.1% | -0.6% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.1 Cr | -4% | -17.5% | -8.6% | Stock Analytics | |
FERMENTA BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FERMENTA BIOTECH | 8.4% |
27.9% |
17% |
| SENSEX | 1.2% |
1.2% |
-5.5% |
You may also like the below Video Courses
